Drag a card by its title · ⚙ to size, swap or remove

The company

Sagimet Biosciences Inc. - Series A

SGMT · Nasdaq

Health CareBiotechnologyJust started moving

SGMT stood above a rising 150-day average in 21 of the last 52 weekly readings, including each of the last 14 weeks. It is 23.8% above that average now. Biotechnology: 18% of its 561 stocks in an uptrend (−14 points in four weeks); Health Care: 28% (−9 points in four weeks).

SEC filings

Statistics

Rotation: Just started moving
Weeks in an uptrend: 14 in a row
Industry in uptrend: 18% -14 in 4 wk
Insider buys, 12 months: $0
Insider sales, 12 months: $9.5M
Officials’ trades on record: 0
Institutions holding: 120 (+38)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 21 of 52 weeks.

21 Apr – 20 Oct

Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months0

Sale orders, 12 months10

Buyers · sellers0 · 5

Who	Did	Shares	Traded
George KembleDirector	sold	350,987at $10.23	14 Aug 2026filed 17 Aug 2026
George KembleDirector	sold	20,206at $9.95	11 Aug 2026filed 12 Aug 2026
George KembleDirector	sold	18,844at $7.46	20 Jul 2026filed 22 Jul 2026
Elizabeth RozekChief Legal & Admin. Officer	sold	10,545at $7.76	20 Jul 2026filed 22 Jul 2026
David HappelPresident & CEO	sold	64,051at $7.76	20 Jul 2026filed 22 Jul 2026
Elizabeth RozekChief Legal & Admin. Officer	sold	2,622at $5.36	10 Feb 2026filed 12 Feb 2026
Eduardo Bruno MartinsChief Medical Officer	sold	3,640at $5.36	10 Feb 2026filed 12 Feb 2026
Thierry ChaucheChief Financial Officer	sold	1,312at $5.36	10 Feb 2026filed 12 Feb 2026
David HappelPresident & CEO	sold	12,101at $5.36	10 Feb 2026filed 12 Feb 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders120+38 on the quarter

New · exited58 · 20

Reported value$394.4M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

Manager	Shares	Change
BlackRock, Inc.added · filed 7 Aug 2026	6,575,788$50.8M	+5,775,845+722.0%
Balyasny Asset Management L.P.new · filed 14 Aug 2026	3,626,113$28.0M	+3,626,113
Woodline Partners LPadded · filed 14 Aug 2026	3,000,652$23.2M	+1,999,709+199.8%
SILVERARC CAPITAL MANAGEMENT, LLCnew · filed 13 Aug 2026	2,927,698$22.6M	+2,927,698
VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026	2,566,272$19.8M	+1,467,353+133.5%
BVF INCnew · filed 14 Aug 2026	2,500,000$19.3M	+2,500,000
Caligan Partners LPnew · filed 14 Aug 2026	2,500,000$19.3M	+2,500,000
Affinity Asset Advisors, LLCadded · filed 13 Aug 2026	2,497,864$19.3M	+1,629,844+187.8%
FEDERATED HERMES, INC.added · filed 12 Aug 2026	2,086,715$16.1M	+2,085,934+267085.0%
GREAT POINT PARTNERS LLCnew · filed 14 Aug 2026	2,029,933$15.7M	+2,029,933